Clinical Trial Update: Bronchodilator Effects and Safety of Glycopyrronium Bromide (25 ug and 50 ug o.d.) in Asthma [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports results from Phase 2 and Phase 3 studies evaluating the bronchodilator effects and safety of glycopyrronium bromide (25 mcg a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Glycopyrronium bromide (glycopyrronium bromide)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-01-16